MedTrace Logo

Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

NCT00241995 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-10-18

No results posted yet for this study

Summary

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Conditions

  • Topiramate
  • Lamotrigine
  • Memnatine
  • Diazepam
  • Placebo

Interventions

DRUG

Anticonvulsants

Sponsors & Collaborators

  • St. Petersburg State Pavlov Medical University

    lead OTHER

Principal Investigators

  • Evgeny M Krupitsky, MD, PhD · St. Petersburg State Pavlov Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00241995 on ClinicalTrials.gov